+91- 99099 19545
info@accuprec.com
World Health Organisation (WHO) has named Dr Soumya Swaminathan as the organisation’s Chief Scientist in a new department. She was formerly the Deputy Director General of Programs of the WHO and incidentally was the first Indian to have held this...
Read More
Roche has announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of adults with extensive-stage small cell lung cancer (ES-SCLC). This approval is based on...
Read More
The Forum on Indian Traditional Medicine FITM organised its first Industry Consultation on Global Promotion of Indian Systems of Medicine at Westview Hall, Davanaman, Sarovar Portico, Bengaluru, on 20/03/2019. Vaidya Shri Rajesh Kotecha, Secretary, Ministry of Ayush was the Chief...
Read More
The President of India, Shri Ram Nath Kovind, in his message on the eve of World Tuberculosis Day, which is observed every year on March 24, has said:- “I am happy to note that World Tuberculosis Day is observed every...
Read More
Gujarat Chamber of Commerce and Industry (GCCI) organised Felicitation Ceremony and Presentation of Lifetime Achievement Award to Padmashri Karsanbhai Patel, Founder & Chiarman of Nirma Group on the occasion of completion of 70 years (1949-2019) of the chamber. Shri Sanjay...
Read More
The Ministry of Health & Family Welfare commemorated the World TB Day with a function to mark the occasion, and reiterated the commitment to eliminating TB in the country by 2025. Ms. Preeti Sudan, Health Secretary presided over the function....
Read More
Global medical device testing services market size is expected to reach USD 13.4 billion by the year 2025, according to a latest report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 11.5% during...
Read More The Ministry of Health & Family Welfare notifies the New Drugs and Clinical Trials Rules, 2019. The new rules will change the regulatory landscape for approval of new drugs and conduct of clinical trials in the country. The new rules...
Read More
Pharma major Lupin Limited (Lupin) announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Holdings SA (LAHSA) and Yoshindo Inc. in Japan, and Lupin (through its Japanese subsidiary, Kyowa Pharmaceutical Industry Co. Ltd) have received...
Read More
International Conference on Microbial Pathogenesis & New Frontiers was organised by the CSIR-Institute of Microbial Technology (IMTech), Chandigarh. Despite availability of various generations of antimicrobials, infectious diseases are ranked among the top ten causes of deaths throughout the world due...
Read More
The Vice President of India, Shri M. Venkaiah Naidu has called for a renewed focus on rural health care and cautioned that the quality of healthcare being delivered cannot be determined by the price being paid. He was delivering the...
Read More
The Vice President of India, Shri M. Venkaiah Naidu has called for medical universities to introduce teachings in human values as a part of the curriculum to inculcate moral, social and ethical values in students. He was delivering the 3rd...
Read More Novartis today announced that the US Food and Drug Administration (FDA) has approved Mayzent®(siponimod) for the treatment of adults with relapsing forms of multiple sclerosis, including secondary progressive multiple sclerosis (SPMS) with active disease, relapsing remitting multiple sclerosis (RRMS) and...
Read More Zydus Cadila announced the Day 1 launch of Tadalafil Tablets USP (US RLD – Cialis Tablets) upon receiving the final approval from the US FDA for marketing the product in the strengths of 2.5 mg, 5 mg, 10 mg, and...
Read More Alembic Pharmaceuticals Limited today announced that the Company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tadalafil Tablets USP, 2.5 mg, 5 mg, 10'mg and 20 mg. The approved ANDA...
Read More
Accuprec Research Labs Pvt. Ltd. © 2024
